Today was published in ERJ: A summary of the new GINA strategy: a roadmap to asthma control!
Over the past 20 years, the Global Initiative for Asthma
(GINA) has regularly published and annually updated a global strategy
for asthma management and prevention that has
formed the basis for many national guidelines. However, uptake of
existing guidelines
is poor. A major revision of the GINA report was
published in 2014, and updated in 2015, reflecting an evolving
understanding
of heterogeneous airways disease, a broader
evidence base, increasing interest in targeted treatment, and evidence
about effective
implementation approaches. During development of
the report, the clinical utility of recommendations and strategies for
their
practical implementation were considered in
parallel with the scientific evidence.
This article provides a summary of key
changes in the GINA report, and their rationale. The changes include a
revised asthma
definition; tools for assessing symptom control and
risk factors for adverse outcomes; expanded indications for inhaled
corticosteroid
therapy; a framework for targeted treatment based
on phenotype, modifiable risk factors, patient preference, and practical
issues; optimisation of medication effectiveness by
addressing inhaler technique and adherence; revised recommendations
about
written asthma action plans; diagnosis and initial
treatment of the asthma−chronic obstructive pulmonary disease overlap
syndrome;
diagnosis in wheezing pre-school children; and
updated strategies for adaptation and implementation of GINA
recommendations.
Full text of the article:
http://erj.ersjournals.com/content/early/2015/07/23/13993003.00853-2015.full
